Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02251015 Completed - Clinical trials for Temporomandibular Disorders

Effects of the Use of Occlusal Splint on the Postural Balance of Individuals With Temporomandibular Disorder

Start date: July 2011
Phase: Phase 3
Study type: Interventional

To investigate the effects of the use of occlusal splint over postural balance in individuals with signs and symptoms of temporomandibular disorder. The research group consists of 49 patients (36 getting occlusal splints and 13 as control group) between 18 and 75 years old, both genders, diagnosed as temporomandibular disorder (TMD) by RDC/TMD questionnaire and magnetic resonance imaging of the temporomandibular joints. The research is a randomized, controlled, prospective clinical study with intervention. Postural equilibrium will be evaluated by means of a force plate. In the randomization, the splinted group was under an occlusal-stability criterion as well as advised under therapeutic exercises while the control group got only orientation about therapeutic exercises. After 12 weeks, the groups were re-evaluated. The results will be analyzed by categorical data using absolute and relative frequencies as well as continuous data using average, median, standard deviation, 25 and 75 percentiles, besides minimum and maximum values; comparison between the times by non-parametric Wilcoxon, Mann-Whitney and ANOVA tests with a threshold of significance of 0.05.

NCT ID: NCT02247986 Withdrawn - Conduct Disorder Clinical Trials

Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder

Start date: September 4, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

Background: - Disruptive behavior is a common problem for children and adolescents. It can be treated with some success with stimulant medicine. Researchers want to learn more about how this works. Objective: - To learn how the brain changes when taking the medicine methylphenidate for behavior problems. Eligibility: - Children ages 10 17 with conduct disorder and/or attention deficit disorder. - Healthy volunteers the same age. Design: - Participants will be screened under a separate protocol. - Participants will have two 3-hour sessions at the clinic. Girls who are menstruating will have a pregnancy test before their scans. - Visit 1: All participants will: - Perform simple tests on a computer. - Fill out a questionnaire along with their parent or guardian. - Have an MRI scan. A magnetic field and radio waves take pictures of the brain. Participants will lie on a table that slides into a metal cylinder. A coil will be placed over their head. They will be in the scanner for 60 minutes, lying still or performing a simple task. They will practice the task before the scan. A computer screen will show them task information during the scan. The scanner makes loud knocking sounds. Participants will get earplugs. Their parent or guardian can stay with them during the scan. - Only participants with behavior disorders will: - Take a pill of the study medicine or placebo. - Be monitored for any side effects. - Visit 2 is a repeat of Visit 1, except participants who got a pill in Visit 1 will get the other pill in Visit 2. For healthy volunteers, the 2 visits are exactly the same.

NCT ID: NCT02246218 Completed - Urea Cycle Disorder Clinical Trials

A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders

Start date: December 31, 2014
Phase: Phase 4
Study type: Interventional

This is an open-label study consisting of a transition period to RAVICTI, followed by a safety extension period for at least 6 months and up to 24 months of treatment with RAVICTI, depending on age at enrollment. It is designed to capture information important for evaluating safety, pharmacokinetics and efficacy in young children. Subjects who are followed by or referred to the Investigator for management of their UCD. Subjects eligible for this study will include patients ranging from newborn to < 2 years of age with either a diagnosed or clinically suspected UCD.

NCT ID: NCT02245776 Withdrawn - Clinical trials for Neurological; Disorder, Nervous System

Stem Cell Therapy in Incurable Neurological Disorders

Start date: December 2008
Phase: Phase 1
Study type: Interventional

The purpose of the study was to analyze the benefit of autologous mononuclear cell therapy in incurable neurological disorders.

NCT ID: NCT02242669 Completed - Depression Clinical Trials

Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders

Start date: November 2014
Phase: N/A
Study type: Observational

The purpose of this study to evaluate peer-led mutual help organizations (MHOs) that target individuals with psychiatric diagnoses such as mood disorders, and provide evidence either supporting the expansion of such groups and the development and testing of clinical procedures, or point toward reevaluation and development of alternative low-cost, community based approaches to promoting recovery among individuals suffering from these disorders.

NCT ID: NCT02238730 Withdrawn - Depression Clinical Trials

Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy

Start date: September 2014
Phase: N/A
Study type: Interventional

To evaluate the equivalent efficacy of ultrabrief pulsewidth right unilateral electroconvulsive therapy versus bitemporal brief pulse electroconvulsive therapy in the treatment of depression and to evaluate the cognitive effects of ultrabrief right unilateral electroconvulsive therapy versus bitemporal brief pulse electroconvulsive therapy.

NCT ID: NCT02237807 Completed - Healthy Clinical Trials

Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions

Start date: September 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the bioequivalence of the investigational TEST product with the marketed REFERENCE products by measurement of Plasma concentrations of Erythromycylamine in plasma and calculation of the bioequivalence parameters from those measurements followed by ANOVA and 90% confidence interval statistical evaluation.

NCT ID: NCT02237768 Completed - Healthy Clinical Trials

Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions

Start date: December 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the bioequivalence of the investigational TEST product with the marketed REFERENCE products by measurement of Plasma concentrations of Erythromycylamine and calculation of the bioequivalence parameters from those measurements followed by ANOVA and 90% confidence interval statistical evaluation.

NCT ID: NCT02237703 Terminated - Trauma Clinical Trials

Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)

Start date: March 2012
Phase: N/A
Study type: Observational

This study uses positron emission tomography (PET) imaging to measure kappa opioid receptors (KOR) in the brains of individuals with and without post-traumatic stress disorder (PTSD). The investigators propose to recruit 45 drug-naïve individuals, N=15 patients with PTSD, N=15 trauma-exposed, but asymptomatic healthy control subjects (TC) and N=15 non-trauma exposed healthy control subjects (HC) to participate in one magnetic resonance imaging (MRI) and one PET study. The investigators will also carefully document trauma history, and collect behavioral and neuroendocrine measures to provide a more integrative view on the neurobiology of PTSD and its phenotype. The investigators predict PTSD will show greater carbon - 11 (11C)[11C]LY2795050 volume of distribution (VT) (i.e. KOR binding) values than control populations in an a priori defined PTSD circuit.

NCT ID: NCT02236780 Recruiting - Clinical trials for In Vitro Fertilisation

Influence of Environmental Conditions on In Vitro Fertilization (IVF) Attempts and Induced Pregnancies

MeteoFIV
Start date: January 2015
Phase: N/A
Study type: Observational

The main purpose of the study is to assess the impact of environmental conditions on live-birth rates after intraconjugal IVF. The second purposes are - to assess the impact on pregnancies (prematurity, preeclampsia); - to assess the impact on newborn's health (stunted growth); - to evaluate the consistency of results observed between assisted pregnancies and spontaneous pregnancies.